✦ LIBER ✦

Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: a focus group study

✍ Scribed by F.A.M Poppelaars; G van der Wal; J.C.C Braspenning; M.C Cornel; L Henneman; M.W Langendam; L.P ten Kate

Book ID: 117200305
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 114 KB
Volume: 117
Category: Article
ISSN: 0033-3506
DOI: 10.1016/s0033-3506(03)00136-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Implementation of preconceptional carrie

Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: A sociotechnical analysis

✍ Roos Achterbergh; Phillis Lakeman; Dirk Stemerding; Ellen H.M. Moors; Martina C. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Imparting carrier status results detecte

Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges

✍ Hilda Parker; Nadeem Qureshi; Fiona Ulph; Joe Kai 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 244 KB

The perspectives of Australian midwifery

The perspectives of Australian midwifery academics on barriers and enablers for simulation in midwifery education in Australia: A focus group study

✍ Stephanie Fox-Young; Susannah Brady; Wendy Brealey; Simon Cooper; Lisa McKenna; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 151 KB

A qualitative study of anticipated barri

A qualitative study of anticipated barriers and facilitators to the implementation of nurse-delivered alcohol screening, brief intervention, and referral to treatment for hospitalized patients in a Veterans Affairs medical center

✍ Broyles, Lauren; Rodriguez, Keri L; Kraemer, Kevin L; Sevick, Mary; Price, Patri 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 312 KB

80* A randomised, double-blind, placebo-

80* A randomised, double-blind, placebo-controlled parallel group study to investigate the safety and efficacy of two doses of tiotropium bromide (2.5 μg and 5 μg) administered once daily via the Respimat® device for 12 weeks in patients with cystic fibrosis

✍ J.S. Elborn; A. Sharma; Q. Deng; P. Koker 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Design and Implementation of a Controlle

Design and Implementation of a Controlled Clinical Trial to Evaluate the Effectiveness and Efficiency of Routine Opt-out Rapid Human Immunodeficiency Virus Screening in the Emergency Department

✍ Jason S. Haukoos; Emily Hopkins; Richard L. Byyny; Amy A. Conroy; Morgan Silverm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB